We compared four immunoassays for serum and urine myoglobin. Within-run cvswere 5-13%, withbiases seen between assays. Myoglobin was stable for 1 month in serum and 12 days in urine when the pH was adjusted to between 8.0 and 9.5. Hemoglobin caused no interference. We assayed 91 pairs of serum and timed urine specimens from 41 patients admitted for acute trauma or rhabdomyolysis. Most were treated with mannitol and alkalinization. Upon initial presentations, 21 patients with either low serum myoglobin concentrations (<400 jzg/L) or high myoglobin clearances ( 4 mi/mm) had normal creatinine clearances and no clinicalevidence of renal disease. The remaining20 had low myoglobin clearances. Seven were in rhabdomyolysis-induced acute renal failure, or subsequently developed this complication. We suggest that low myoglobin clearance may indicate a high risk for developing renal failure or may be an early marker for kidney dysfunction.
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Myoglobm, a low-molecular-mass protein found in striated muscles, is released from muscle cells after injury to the skeletal muscles or myocardium and appears in the circulation within a few hours. Numerous case reports implicate high myoglobin concentrations as a cause of acute renal failure (ARF) (1) (2) (3) (4) . Although the induction of renal disease by myoglobin in patients with crush injuries has been suspected since World War 11 (5, 6) , the underlying pathogenesis is still largely unknown (7) . One theory is that under acidicconditions, myoglobin precipitates directly within renal tubules leading to obstruction, an increase in intratubular pressure, and inhibition of the glomerular filtration rate (8). Other studies suggest that inorganic iron causes direct kidney damage through lipid peroxidation and cytotoxicity of proximal tubules (9, 10). Prospective studies have indicated that prophylactictreatment of patients with extensive skeletal muscle injury with mannitol and sodium bicarbonate reduces the prevalence of renal damage, such patients (12) . Maintenance of optimal acid-base and electrolyte balance, and the assessment of renal and cardiac function, however, is complicated when such treatments are used. In addition, there is a risk of congestive heart failure when critically ill or injured patients are treated with mannitol (8).
Urine myoglobin is qualitatively measured in many laboratories with a urinalysis dipstick. Hemoglobin is also reactive to these dipstick pads, necessitating its removal by addition of 80% saturated ammonium sulfate and centrifugation (13), or by passage through a' microconcentrator membrane (14). The salt precipitation method is insensitive, and can produce false-positive results with incomplete removal of hemoglobin and false-negative results if myoglobin is also removed by this process. This has prompted some investigators to believe that the dipstick assay should be abandoned (7).
Quantitative RIAs for myoglobin have been available since the late 1970s and are considerable improvements to the qualitative dipstick assay (15). However, they are laborious, time consuming, and not practical for emergency analysis. Nonisotopicimmunoassays are currently available for the quantitative measurement of myoglobin in serum (16-18), but, at the time we began this study, none was approved for use with urine. We report here the use of these serum assays for urine, and describe the clinical application of serum and urine myoglobin measurements in patients with skeletal muscle injury. for serum creatinine were 7-17 mgfL (males) and 4-15 mgfL (females), and for creatinine clearance, 97-137 mL/min (males)and 35-124 mL/min (females). For total CK, the upper reference limit for males and females was 230 and 150 U/L, respectively.
MaterIals and Methods

Assays and Controls
Urine pH was measured with pH paper or with a glass electrode and pH meter.
Experimental Procedures
Precision.
We used commercial low, medium, and high controls (Behring) for evaluation of the serum assay, and patients' pooled urine samples for the urine assay. The pH of the urine pools was not adjusted before analysis.
Within-run CVs were calculated from 20 doterminations.
Between 
Clinical Procedures
Reference ranges. For the determination of the reference range, we obtained 50 serum and 52 urine specimens from laboratory personnel and from apparently healthy individuals seen at an outpatient clinic. Urine creatinine was measured on 32 of these 52 normal samples.
Clinical study on trauma patients. This study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 1983. We obtained serum and timed urine specimens (usually 2-or 8-h) from 41 patients who were admitted to the surgical intensive care units at Hermann (Houston, TX) and Hartford Hospitals (Hartford, CT) for rhabdomyolysis or trauma from motor vehicle accidents. However, not all of these patients had extensive skeletal muscle damage as a result of these injuries. The diagnoses included drug abuse, fractures of the femur, pelvis, face, and lumbar/thoracic spine, general skeletal muscle ischemin, and closed head injury. In seven of these patients, a diagnosis of ARF was made on the basis of clinical history and laboratory results including urine volume, urinalysis, osmolality, blood urea nitrogen and serum creatinine concentrations, and creatinine clearances. Myoglobin results from the Opus Plus analyzer were used in the clinical study. Serum samples were collected into evacuated red-top tubes (Becton Dickinson, Rutherford, NJ) and centrifuged before analysis. Urine specimens were collected without preservatives and stored at 2-8#{176}C if analyzed within 8 h, or stored at -20#{176}C or lower if the analysis was 8-72 h after collection. All of the data for the clinical study were from urine assayed within 72 h after collection. Stored serum and urine specimens were used to determine the analytical correlation between instruments.
For a given group of samples, all assays were performed on the same day. Urine samples were assayed immediately, or adjusted to a pH between 8.0 and 9.5 with 0.1 mo]JL NaOH before analysis. Myoglo. bin clearances (mllmin) were calculated by multiplying the volume of urine flow (mLjmin) times the ratio of urine to serum myoglobin concentrations.
Unlike creatmine clearance, which is an estimate of glomerular filtration rate, myoglobin clearance is a function of both filtration and tubular catabolism. 
Results
Analytical Study
Precision. The within-run CVs for serum on the Opus Plus were 6.7, 5.7, and 7.0% for the low, medium, and high controls(50, 107, and 268 gIL), respectively. The day-to-day CVs for these controls were 6.7, 5.1, and 7.8%. For urine, the within-run CVs were 7.5, 11.9, and 13.2% for urine myoglobin concentrations of 4, 45, and 1324 igfL, respectively.
The day-to-day CVs were 20.0, 14.6, and 14.5%, respectively.
The day-to-day CV for the urine pool was adversely affected by the instability of myoglobin at low pHs, and was improved to values seen for serum when the pH of the urine poo1 was adjusted to between 8.0 and 9.5 before analysis.
The CVs for the other analyzers for serum and urine myoglobin also ranged from 5% to 15% (data not shown).
Stability. We determined that myoglobin is stable in serum for at least 1 month when stored at 2-8#{176}C. Myoglobin recovery in serum was within 15% for the low pool (mean 55 pg/L) and 10% for the medium and high pools (mean 115 and 300 /2g/L) after 28 days. For urine, the stability of myoglobin is dependent on the pH. As shown in Fig. 1 , urine samples at pH 5.5 degrade within a few days, even when stored at -70#{176}C. In contrast, samples adjusted to between pH 8.0 and 9.0 exhibited good stability after refrigeration and freezing. We recommend that samples be analyzed immediately, or alkalinized before storage at 2-8#{176}C. Our observations of these samples in vitro are similar to clinical observations in vivo: Myoglobin stability and clearance is aided when the pH of urine is high.
Linearity. Because very high myoglobin concentrations are often seen in the urine of trauma patients,it was important to determine if the protein-based serum diluent supplied with each kit could be used as a diluent for urine. We diluted high myoglobin samples and plotted observed (y) vs expected (x) myoglobin concentrations. (results not shown) .
Recovery. Table 1 shows that the recovery of myoglobin in urine was 100-117%, mean 108%. These results are within the precision for the urine assay.
Hemoglobin interference studies. We detected no significant difference in apparent myoglobin concentrations on either the Opus Plus or Stratus II when urine was supplemented with up to 10 g/L hemoglobin.
Analytical correlation between methods. Table 2 summarizes the Deming correlations between the serum and urine assays. Although acceptablecorrelationcoefficients were observed, there were significant proportional biases in these data sets. The Stratus II assay Table 2 ). Higher y-intercepts were reported, however, because the range of myoglobin concentrations used in the correlation study was higher.
Clinical Studies
Reference ranges. The reference range for myoglobin in serum was determined from a population of healthy individuals.
The mean (SD, range) for the Opus Plus was 23.7 jtgfL (18.1, 6.6-120 Fig. 2B) . For the Nephelometer and Stratus II, all but nine and two of the urine specimens, respectively, were below the detectionlimit of 1.2 p.gfL. Based on these values, we used a reference range of 0-7.0 j.gfL for the Opus Plus assay and 0-4.0 j.g/L for the Nephelometer and Stratus II. For the Opus Plus, using the central 95% of the reference population, we determined the reference range for urine to be 1.3-17 g myoglobin/g creatinine.
We also studied the distribution of normal urine myoglobin results with respect to age and exercise status. In contrast to normal ranges reported for total CK (21), no significant difference in mean results was observed in any of these groups (P <0.005).
Patients. The results of samples collected from trauma and rhabdomyolysis patients are summarized in Table  3 . The urine pH range was similar for all groups and offered no discriminatory ability for predicting renal problems. Total CK was slightly lower in sera of patients with minimal myoglobin release (group A), indicating the minor extent of skeletalmuscle injury. Significantly higher total CK was seen in patients in group B than in group A (P <0.05), indicating a higher degree of muscle injury (Table 3) . However, no significant difference was observed when comparing CK values between groups B, C, and ARF patients.
Bettercorrelation was seen with myoglobin clearance values and clinical outcome for ARF. Samples from patients in group A all had normal or high creatinine clearances (mean 172 mL/min, Table 3 ), and none had any clinical or laboratory evidence of renal dysfunction. Only one of these patients had a urine myoglobin concentration >1000 p.g/L. Mean creatinine clearance values in this group were higher than the upper reference limit of 137 mL/min; this may have been caused by the increased release of creatinine from skeletal muscles from trauma (8). Inaccuracies in urine volume may also have artificially increased clearances, since bladder rinses were not used to empty the contents before the collection of urine. Fig. 3A ifiustrates data from one patient from group A with minor skeletal muscle injury. 13.3 43.6 Days Days from this patient. The myoglobin clearance was low, indicating minor skeletal muscle injury or the ability of renal tubules to suffIciently catabolize the amount of filtered myoglobin.
High creatinine and myoglobin clearanceswere observed for patients in group B. The mean creatinine clearance for this group (114 mJ.dmin, Group C patients had decreased myoglobin clearance with significantly lower mean creatinine clearances(87 mljmin) when compared with patients in either groups A or B (P <0.005, Table 3 ). None of these patients was in renal failure at the time of sample collection. The mean myoglobin clearances in this group were low and were within the range of values observed for patients with ARF (Table 3) ; 12 of 20 patients had a urine myoglobin concentration that was <1000 tgfL. One of these patients developed ARF. In the remaining eight with urine myoglobin concentrations >1000 zg/L, three developed ARF. Fig. 3C is from a patient who had a low myoglobin clearance at admission and was possibly at high risk for ARF. With therapy, serum myoglobin concentrations decreased with a concomitant increase in myoglobin clearance, indicating that therapy was successful in removing myoglobin. On day 3, we predicted that this patient would be at low risk for acute tubular failure unless additional skeletal muscle injury and release of myoglobin occurred. The data on days 5 and 6 demonstrated no renal impairment on the basis of creatinine clearance,and urine myoglobin concentrations returned to normal.
Retrospectivereview of the medical record revealed that this patient had only a single episode of acute muscle injury that resolved within 2-3 days.
The results of the seven patients with rhabdomyolysis-induced renal failure are given in Table 4 . Creatinine and myoglobin clearances were decreased in all samples tested from this group. Fig. 3D shows the results of samples collected on one rhabdomyolysis patient. Before onset of ARF, this patient had high serum and very high urine myoglobin concentrations. Unlike the case in Fig. 3B , however, the myoglobin clearance was low and the patient was classified into the high-risk group C. Acute nonoliguric renal failure developed within a few days after admission, as demonstrated by increasing blood urea nitrogen and creatinine concentrations, and a low creatinine clearance.
Discussion
The development of ARF is highly complex and dependent on many factors such as plasma renal flow, urine flow rate, tubular fluid pH and salt concentrations, and the condition of the kidneys. Severe skeletal muscle disease or injury is also an important cause of ARF. Measurement of total CK in serum is important in assessingthe extent of skeletal muscle turnover in these patients. For predictionof renal failure, however, our data show that total CK values do not distinguish patients in group B (no renal failure) from groups C (higher risk) and D (renal failure).
Qualitative dipstick assay for urine myoglobin after precipitation of hemoglobin has been used for years as a basis for initiating prophylactic therapy, although numerous false positives and negatives may result. As a more useful approach, we examined rapid quantitative immunoassays for myoglobin on serially collected timed urine, in conjunction with quantitative myoglobin results on serum collected at the same time.
There are several possible interpretations of our data. Because myoglobinuria has been identified as a cause of renal failure, we tried to determine if myoglobin clearance measurements can be prospectively used to determine risk for ARF. Feinfeld et al.found that four of five patients with myoglobin concentrations >1000 tg'L at admission developed renal failure (2). In our study, only six of 20 patients with urine myoglobin concentrations >1000 j.tgfL had or developed renal failure. In contrast, all of our patients with rhabdomyolysis-induced renal failure had myoglobin clearances <4 mLdmin. We suggest that in the presence of high serum myoglobin concentrations, a low urine myoglobin clearance rate indicates a high risk for subsequent renal disease. We considered this group to be at high risk because four of seven rhabdomyolysis-induced ARF patients initially had serum myoglobin concentrations and clearances that were in this range before the onset of renal failure. In contrast, patients with high serum myoglobin concentrations and clearances ( 4 mL/min) had adequate renal function and only one developed kidney failure. For example, the patient shown in Fig. 3C had very high urine myoglobin concentrations, but had no subsequent renal problems.
Because the myoglobin clearance was high, the rate of renal excretion exceeded the rate of release from the injured tissue. A low myoglobin clearance alone does not necessarily indicate a risk for renal damage, because patients with minor striatedmuscle Table 4 . Mean laboratory results for IndIvidual patIents wIth renal faIlure.
